A student-run resource for reliable reports on the latest law and technology news

Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott 

Written By: Hyeongsu Park - Edited By: Kendra Albert

The market for therapeutic antibodies is projected to reach hundreds of billion dollars within the next several years. In Centocor v. Abbott, the Court of Appeals for the Federal Circuit (“Federal Circuit”) held that a patentee cannot claim an antibody unless the specification describes it, even if he/she fully characterizes the antigen, and the court vacated a $1.67 billion jury verdict, the largest patent infringement award in U.S. history.

Read More...

Posted On Mar - 13 - 2014 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
unlock_cell_phone

The Court of Justice

By Ann Kristin Glenster - Edited by David Nathaniel Tan Introduction On October 6, ...

Fed. Cir. Flash Digest

Flash Digest: News i

By Yiran Zhang – Edited by Olga Slobodyanyuk Senators Introduce a ...

Icon-news

Flash Digest: News i

By David Nathaniel Tan - Edited by Adi Kamdar Software Pirate ...

1271084_10152203108461729_809245696_o

Belgian Court Demand

By Mila Owen – Edited by Kayla Haran Belgian Privacy Commission ...

Sikhs for Justice Logo

Facebook not liable

By Ann Kristin Glenster – Edited by Yaping Zhang Sikhs for ...